• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Global Market for Biomarkers, 2015-2020 (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)

$1,396.50 – $2,793.00

Clear
SKU: KLI5789361 Category: Biotechnology Market Research Pages: 683
  • Description
  • Table of Contents
  • Latest reports

Description

The Global Market for Biomarkers (Cancer Biomarkers, Cardiovascular Disease Biomarkers, Immunological Disease Biomarkers, Infectious Disease Biomarkers, Neurological Disease Biomarkers, Novel Biomarkers for Other Diseases)

The Global Market for Biomarkers analyzes the current and future markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers:

  • The Market for Cancer Biomarkers
  • The Market for Cardiovascular Disease Biomarkers
  • The Market for Immunological Disease Biomarkers
  • The Market for Infectious Disease Biomarkers
  • The Market for Neurological Disease Biomarkers
  • The Market for Novel Biomarkers for Other Diseases

For each area, selected biomarkers and companies developing/marketing these biomarkers are provided.

Market analyses in this report cover world markets for biomarker diagnostic markets, including the following segmentation:

  • Worldwide Diagnostic Biomarker Market by Disease Indication – 2015 and 2020
  • Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Cardiovascular Disease Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Autoimmune Disease and Allergy Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Infectious Disease Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Diagnostic Market for Selected Other Biomarkers – 2015 and 2020
  • Worldwide Biomarker Market – Diagnostic versus Research Applications – 2015 and 2020
  • Worldwide Biomarker Market by Geography – 2015 and 2020 (North America, European Union, Japan, ROW, Total)

The world markets for biomarkers and biomarker tests are provided in U.S. dollars for 2015 and 2020. The worldwide market for biomarkers by disease indication is provided, including the market for tests for biomarkers (diagnostics products) sold to clinical laboratories, and also products sold to researchers.

Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Biomarkers also have important roles in drug discovery and development.

The biomarker market is large, reflecting the large market for diagnostic tests based on these biomarkers, and also the ongoing efforts to discovery, validate, and commercialize new biomarkers. Growth in this market is fueled by factors that are fostering the growth of both the research and the diagnostics market. Market drivers and challenges are discussed in the report.

The large and growing biomarker market has attracted a lot of attention, and companies entering the market. Thus this has become a highly competitive market. The report profiles companies involved in the biomarkers market.

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author’s industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Table of Contents

ONE: EXECUTIVE SUMMARY

Overview

Scope and Methodology

Market Overview

Prognosis for Growth

TWO: INTRODUCTION

What Are Biomarkers?

Point-of-View

THREE: SELECTED TECHNOLOGIES USED TO IDENTIFY AND ANALYZE BIOMARKERS

Immunoassays

Overview – Immunoassays

Immunoassay Instrument Platforms

Immunohistochemistry (IHC)

Flow Cytometry

In Situ Hybridization

Nucleic Acid Amplification Technologies

Analysis of Gene Expression Patterns (Gene Signatures)

Microarrays

Protein Microarrays

DNA Microarrays

Chromosomal Microarrays

Tissue Microarrays

Sequencing Technologies

Sanger Sequencing

Early Next Generation Sequencing Technologies

Sequencing by Synthesis (SBS)

Supported Oligonucleotide Ligation and Detection (SOLiD)

Ion Torrent Sequencing

Newer Next Generation Sequencing Technologies

Sequencing Technologies Summary – Impact on Biomarkers

Mass Spectrometry

Mass Spectrometry Technology

Research and Clinical Applications of Mass Spectrometry

Non-Invasive Prenatal Testing

Liquid Biopsies – Circulating Tumor Cells and Circulating Tumor DNA(Cell Free DNA)

Digital Pathology and Image Cytometry

Information Technology

FOUR: CANCER BIOMARKERS

Overview

Cancer Biomarkers

Assessing Risk of Cancer

Cancer Screening

Diagnosis and Monitoring of Cancer

Predicting Prognosis

Personalized Medicine/Precision Testing

Competition in Cancer Biomarkers

FIVE: CARDIOVASCULAR DISEASE BIOMARKERS

Overview

Acute Myocardial Infarction and Acute Coronary Syndrome

Heart Failure

Lipid Disorders

SIX: IMMUNOLOGICAL DISEASE BIOMARKERS

Autoimmune Disease Biomarkers

Inflammation/Inflammatory Disease Biomarkers

Selected Other Immune-Related Disorders

SEVEN: INFECTIOUS DISEASE BIOMARKERS

Overview

Current Infectious Disease Diagnostics and Emerging Threats

Antibiotic Resistance

Sepsis

EIGHT: NEUROLOGICAL DISEASE BIOMARKERS

Overview

Alzheimer’s Disease

Emerging Biomarkers for Neurological Disorders

NINE: NOVEL BIOMARKERS FOR OTHER DISEASES

Overview

Companies Developing Novel Biomarkers

TEN: DEALS

ELEVEN: BIOMARKERS – MARKET DRIVERS AND CHALLENGE

Biomarker Markets

Market Drivers for Diagnostic Applications of Biomarkers

Issues and Hurdles Faced by In Vitro Diagnostic Companies

Market Drivers for Research Applications of Biomarkers

Biomarkers in Drug Development

Pharmacogenomic Biomarkers

Advances in Technology Changing the Future of Biomarkers

Biomarker Panels

Working Together to Discover and Validate New Biomarkers – Alliances,

Consortiums, and Other Groups

Validation of Biomarkers

Future Prospects

TWELVE: BIOMARKER MARKET ANALYSIS

Diagnostic Biomarker Market by Disease Indication

Cancer Biomarkers

Cardiovascular Disease Biomarkers

Autoimmune Disease and Allergy Biomarkers

Infectious Disease Biomarkers

Biomarkers for Other Diseases

Biomarker Market – Research versus Diagnostic Applications

Biomarker Market – Geographical Distribution

THIRTEEN: COMPANY PROFILES: BIOMARKER COMPANIES

14M Genomics Ltd.

20/20 GeneSystems, Inc

23andMe, Inc.

A&G Pharmaceutical, Inc.

Abacus Diagnostica Oy

Abbott Laboratories

Recent Revenue History

Company Overview – Focusing on Biomarkers

Abcodia Ltd.

Accelerate Diagnostics, Inc.

Recent Revenue History

Company Overview

Acobiom

ACT Genomics Co., Ltd.

Acumen Pharmaceuticals, Inc.

Adaptive Biotechnologies Corporation

Adlyfe Inc.

Admera Health (A GENEWIZ Company)

AESKU.DIAGNOSTICS

Affymetrix, Inc.

Recent Revenue History

Company Overview

Agena Bioscience Inc.

Agendia NV

Agilent Technologies Inc.

Recent Revenue History

Company Overview

Alere Inc.

Recent Revenue History

Company Overview

Almac Group Limited

ALPCO

Amarantus BioScience Holdings, Inc.

Ambry Genetics Corp.

Aperiomics, Inc.

ApoCell, Inc.

Applied Proteomics, Inc.

Associates of Cape Cod, Inc. (ACC)

Asuragen, Inc.

AsymmetRx Medical, Inc.

Athena Diagnostics, Inc. (A Quest Diagnostics Business)

Atlas Genetics Ltd

Atossa Genetics Inc.

Recent Revenue History

Company Overview

Augurex Life Sciences Corp.

Augurix SA/Augurix Diagnostics

Avant Diagnostics, Inc. (Formerly Arrayit Diagnostics Inc.)

Axela, Inc

Axis-Shield Diagnostics, Ltd. (An Alere Company)

Recent Revenue History

Company Overview

AXO Science

Banyan Biomarkers, Inc.

Beckman Coulter, Inc.

Recent Revenue History

Company Overview

Becton, Dickinson and Company (BD)

Recent Revenue History

Company Overview

BG Medicine, Inc.

Recent Revenue History

Company Overview

The Binding Site Group Ltd.

Recent Revenue History

Company Overview

Biocartis SA

Recent Revenue History

Company Overview

Biocrates Life Sciences AG

Biodesix, Inc.

BioFire Diagnostics, LLC (Acquired by bioMérieux)

Recent Revenue History and Other Financial Information

Company Overview

Biohit Oyj

Recent Revenue History

Company Overview

Bioinnovation Solutions SA

BioMarker Strategies

BioMedomics, Inc.

bioMérieux SA

Recent Revenue History

Company Overview

BioMosaics Inc.

BioPorto Diagnostics A/S

Recent Revenue History

Company Overview

Bio-Rad Laboratories, Inc.

Recent Revenue History

Company Overview

BioSystems International

bioTheranostics, Inc. (A bioMérieux Company)

Biotype Diagnostic GmbH

BIOUNIVERSA s.r.l.

Cancer Genetics, Inc.

Recent Revenue History

Company Overview

Caprion, Inc.

CardioDx, Inc.

CardioGenics Holdings Inc.

CareDx, Inc.

Recent Revenue History

Company Overview

Caris Life Sciences

Castle Biosciences, Inc.

CD Diagnostics, Inc.

Cellmid Ltd.

Centogene AG

Cepheid

Recent Revenue History

Company Overview

Chronix Biomedical, Inc.

Clarient Diagnostic Services, Inc. (A GE Healthcare Company; Being Acquired by

NeoGenomics, Inc.)

Recent Revenue History

Company Overview

Courtagen Life Sciences, Inc.

Crescendo Bioscience (Subsidiary of Myriad Genetics)

Critical Diagnostics

Curetis AG

Cynvenio Biosystems, Inc.

Dako A/S (An Agilent Company)

Recent Revenue History

Company Overview

Danaher Corporation

Recent Revenue History

Company Overview

deCODE genetics

Diadexus, Inc

Recent Revenue History

Company Overview

DiaGenic ASA

Diagenics SE

Diagenics International Corporation

Diaxonhit

Recent Revenue History

Company Overview

DNA Electronics Ltd. (DNAe)

EntroGen, Inc.

Epic Sciences, Inc.

Epigenomics AG

Recent Revenue History

Company Overview

Epinex Diagnostics, Inc.

Eutropics Pharmaceuticals

Exact Sciences Corporation

Recent Revenue History

Company Overview

Exiqon A/S

Recent Revenue History

Company Overview

Foundation Medicine, Inc.

Recent Revenue History

Company Overview

Fujirebio Inc.

Fujirebio Diagnositics, Inc.

Recent Revenue History

Company Overview

Gamma Therapeutics, Inc.

Genalyte, Inc.

GeneCentric Diagnostics, Inc.

Genection, Inc. (An Invivoscribe Company)

GeneNews Limited and Innovative Diagnostic Laboratory

GenomeDx Biosciences

Genomeon LLC

Genomic Health, Inc.

Recent Revenue History

Company Overview

Genomic Vision

Recent Revenue History

Company Overview

Genoptix (A Novartis Company)

Guardant Health, Inc.

HalioDx

Helomics Corporation

Hologic, Inc.

Recent Revenue History

Company Overview

Illumina, Inc.

Recent Revenue History

Company Overview

Immunexpress

Integrated Diagnostics, Inc.

Intrinsic LifeSciences

Myriad Genetics, Inc.

Recent Revenue History

Company Overview

NanoString Technologies, Inc.

Recent Revenue History

Company Overview

NeoGenomics, Inc./NeoGenomics Laboratories

Recent Revenue History

Company Overview

Oncolab, Inc.

Oncospire Genomics

OPKO Health, Inc./OPKO Diagnostics

Recent Revenue History

Company Overview

ORGENTEC Diagnostika GmbH

Orion Genomics

Ortho-Clinical Diagnostics

Recent Revenue History

Company Overview

Oxford Gene Technology

Proteome Sciences plc

Recent Revenue History

Company Overview

Psynova Neurotech Ltd.

QIAGEN N.V.

Recent Revenue History

Company Overview

Quanterix Corporation

Randox Laboratories Ltd

Rapid Pathogen Screening, Inc.

ReLIA Diagnostics, Inc.

RENESE UG

Roche

Recent Revenue History

Company Overview

Siemens Healthcare Diagnostics

Recent Revenue History

Company Overview

Sysmex Corporation

Recent Revenue History

Company Overview

Thermo Fisher Scientific, Inc.

Recent Revenue History

Company Overview

Tosoh Corporation

Recent Revenue History

Company Overview

Ventana Medical Systems, Inc. (Member of the Roche Group)

Wako Pure Chemical Industries, Ltd.,

XRGenomics LTD

ZEUS Scientific, Inc.

 

    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024
    September 11, 2024
    Worldwide Sequencer Market, 2023-2028
    August 8, 2024
    The Worldwide Market for Liquid Biopsy, 6th Edition
    December 29, 2023
    The Market for RNA Sequencing, 3rd Edition
    September 8, 2023

Related products

  • Placeholder image

    Wound Care Markets, 3rd. Edition, Vol. I – Skin Ulcers

    $2,995.00 – $5,990.00
  • Placeholder image

    SNP Genotyping and Analysis Markets

    $1,995.00 – $7,990.00
  • Placeholder image

    Stem Cells – Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

    $995.00 – $7,800.00
  • Placeholder image

    U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays, 2nd Ed.

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020Hologic: Company Profile
Scroll to top